About
Hagai Marmor-Kollet is an Associate at aMoon Growth, where he sources and evaluates late-stage investment opportunities in life science tools and diagnostics. He previously served as Platform Team Lead at 1E Therapeutics working on oligonucleotide-based therapies, and contributed to cancer diagnostic test development at Rosetta Genomics. He holds an MSc and PhD from the Weizmann Institute of Science and was later a staff scientist at Massachusetts General Hospital and Harvard Medical School, leading translational research in neurodegeneration and pain.
Invests in
BiotechDigital HealthMedical Devices
Experience
- aMoon FundGrowth Investment Teamcurrent2025 — presentBoston, Massachusetts, United States
- 1E TherapeuticsAssociate Director - Research Team Leader2021 — 2023
- 1E TherapeuticsSenior Scientist2021Rehovot, Center District, Israel
- Rosetta GenomicsAssociate Researcher2014 — 2017
- Israel Defense ForcesCombat officer in Golani2004 — 2009
Education
- Harvard Medical School - Massachusetts General HospitalStaff Scientist2024 — 2025
- Weizmann Institute of ScienceDoctor of Philosophy - PhD, Molecular Biology2017 — 2021
- Weizmann Institute of ScienceMaster's Degree, Molecular Biology2012 — 2014
- The Hebrew University of JerusalemBsc, Chemistry and Biology2009 — 2012
Skills & more
Investigational New Drug Application (IND)LeadershipCommunicationMentoringPublicationsGene TherapyNext-Generation Sequencing (NGS)Droplet Digital PCR (ddPCR)High Throughput ScreeningStress ManagementScientific CommunicationsNetworking
+12 more
Operations ManagementiPSC Cell CultureProteomicsData AnalysisNeurodegenerative DiseaseLead OptimisationDrug DevelopmentProject ManagementMedicinal ChemistryDrug DiscoveryTarget IdentificationCell Based AssaysLanguages English · French · Hebrew
From Hagai's professional profile.
Same school
Also attended Harvard Medical School - Massachusetts General Hospital3
Also attended Weizmann Institute of Science16
Yaron DanielyGeneral Partner & Head of aMoon Alpha at aMoonReut ShemaPartner at aMoonPete FlintInvestor at NFXShiran Tehila MashiahPrincipal at Peregrine VenturesYoni CheifetzPartner at Lightspeed Venture PartnersEugen SteinerVenture Partner | MD PhD at HealthCap
+ 10 more
Also attended The Hebrew University of Jerusalem138
Lisa CohenInvestment Director at Intel CapitalMiri FentonAssociate at Maverick Ventures IsraelTamar YehoshuaInvestor at IVP (Institutional Venture Partners)Rutie AdarInvestments & Innovation Sr. Director, Israel at Samsung Catalyst FundJack LevyInvestor at Israel Cleantech VenturesRony Patishi-ChillimInvestor at Israel Cleantech Ventures
+ 132 more
